CompoAtlas

Menopause avec fenugrec L theanine et safran

Food supplement declared in France, decision dated 21 March 2026

Menopause avec fenugrec L theanine et safran (argalys) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: théanine 100 mg per day, Trigonella foenum-graecum 500 mg per day, Crocus sativus 20 mg per day, Magnesium, Vitamin B12. 1 rule of use applies to its ingredients (limits and warnings).

Brand
argalys
Food business operator placing the product on the market
argalys sas
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
deux gélules
Directions for use
prendre une gélule le matin et une le soir avec un verre d'eau
Intended populations
Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women
Objectives stated by the manufacturer (these are not authorised claims)
Menopause

Declaration 360363, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Trigonella foenum-graecum L.GraineExtrait sec aqueux500 mg
Crocus sativus L.FleurExtrait sec hydroalcoolique20 mg

Substances

NamePer day
théanine100 mg

Other active ingredients

NamePer day
Fibres solubles d'acacianot declared
Son de riznot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
magnesium bisglycinateMagnesium250 mg300 mg
cyanocobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)
DL-alpha-tocopheryl acetateVitamin E300 mg30 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Complément alimentaire réservé aux femmes adultes pour le soulagement des symptômes de la ménopause, sans perturbateurs hormonaux. Déconseillé aux femmes enceintes et allaitantes. Ne se substitue pas à une alimentation équilibrée, tenir hors de portée des enfants, respecter la dose recommandée.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Trigonella foenum-graecum L.
    Read the warning, when it applies and the studies cited

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
    • Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An Evidence-Based Approach. New York (NY): Taylor and Francis; 2006.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 29 May 2026

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 29 May 2026

  • théanine
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : argalys

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Menopause avec fenugrec L theanine et safran (argalys): composition and regulation”, https://compoatlas.com/en/supplements/products/360363-menopause-avec-fenugrec-l-theanine-et-safran, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line